LOS ANGELES CAPITAL MANAGEMENT LLC
Position in PTCT — Ptc Therapeutics, Inc.
CIK 1177206
LOS ANGELES, CA
Position in PTCT
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$4,882,195
+$2,419,496 QoQ
Shares Held
71,660
+121.0% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 22.845380965671225.ToString("F0")%
Shared 0.ToString("F0")%
None 77.15461903432877.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $690,033,476 across 153 Biotechnology names. PTCT ranks #11 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
2,144,847 | $201,872,999 | |
| 2 | EXEL |
Exelixis, Inc.
|
3,102,634 | $133,071,972 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,880 | $60,945,843 | |
| 4 | RPRX |
Royalty Pharma plc
|
971,927 | $46,623,338 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
689,915 | $44,589,206 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
2,289,602 | $40,938,083 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
88,278 | $29,208,541 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
64,937 | $28,996,967 |
All Filings in PTCT
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,882,195 | 71,660 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,462,699 | 32,421 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,911,822 | 47,447 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $2,242,195 | 45,909 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $772,757 | 15,164 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $682,968 | 15,130 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $561,323 | 15,130 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $330,416 | 10,805 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $314,172 | 10,800 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $241,866 | 8,776 | Shares | Sole | 2024-02-06 | |
| 2023-06-30 | $259,596 | 6,383 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $238,131 | 4,916 | Shares | Sole | 2023-05-04 | |
| 2021-03-31 | $252,470 | 5,332 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $386,136 | 6,327 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $744,961 | 15,935 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $994,605 | 19,602 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $835,545 | 18,730 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||